RHUMBLINE ADVISERS - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,793,412
+8.0%
87,527
+4.7%
0.00%0.0%
Q2 2023$1,660,357
+104985.9%
83,561
-9.4%
0.00%0.0%
Q1 2023$1,580
-5.2%
92,222
+8.3%
0.00%0.0%
Q4 2022$1,667
-99.9%
85,192
+21.3%
0.00%0.0%
Q3 2022$1,121,000
+22.9%
70,256
+6.0%
0.00%
+100.0%
Q2 2022$912,000
+28.8%
66,295
+48.5%
0.00%0.0%
Q1 2022$708,000
-24.7%
44,652
+3.7%
0.00%0.0%
Q4 2021$940,000
-29.2%
43,077
-3.0%
0.00%
-50.0%
Q3 2021$1,327,000
-29.8%
44,396
+4.0%
0.00%0.0%
Q2 2021$1,890,000
-0.8%
42,684
-0.6%
0.00%
-33.3%
Q1 2021$1,905,000
-24.4%
42,939
-6.5%
0.00%0.0%
Q4 2020$2,519,000
+142.0%
45,940
+0.9%
0.00%
+50.0%
Q3 2020$1,041,000
-3.4%
45,533
-11.6%
0.00%0.0%
Q2 2020$1,078,000
+96.0%
51,483
+30.5%
0.00%
+100.0%
Q1 2020$550,000
-35.5%
39,442
+5.2%
0.00%0.0%
Q4 2019$853,000
+98.8%
37,493
+1.8%
0.00%0.0%
Q3 2019$429,000
-22.6%
36,823
-0.4%
0.00%0.0%
Q2 2019$554,000
+3.0%
36,963
+20.4%
0.00%0.0%
Q1 2019$538,000
+29.0%
30,695
+9.1%
0.00%0.0%
Q4 2018$417,000
-11.3%
28,122
+47.3%
0.00%0.0%
Q3 2018$470,000
+18.1%
19,086
-5.9%
0.00%0.0%
Q2 2018$398,00020,2870.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders